MOSCOW (Pakistan Point News / Sputnik - 10th November, 2021) Clinical trials of a Russian medicine containing antibodies for coronavirus patients will begin in January 2022, they will be completed within 3-4 months, Alexander Gintsburg, director of Russia's Gamaleya National Research Center of Epidemiology and Microbiology, told Sputnik.
"We will start clinical trials in January next year, and I hope that we will complete these clinical trials within three to four months," Gintsburg said.
